Randall E. Woods
Randall E. Woods is a serial life science entrepreneur, pharmaceutical and biotechnology executive. Mr. Woods brings more than 40 years of experience to the biotech/pharmaceutical arena, and currently serves as the Chief Executive Officer of Sophiris Bio, a publicly traded biotechnology company on the NASDAQ (SPHS) focused on the development of urological drugs. He also served as President and CEO at NovaCardia, Inc. prior to its acquisition by Merck & Co., and nearly eight years as the Chief Executive Officer of Corvas International, Inc., a publicly traded biopharmaceutical company focused on cardiovascular disease and cancer, acquired by Dendreon. Prior to Corvas, Mr. Woods was President of Boehringer Mannheim’s US Pharmaceutical operations and spent over 20 years at Eli Lilly & Company in sales and marketing positions. Mr. Woods served as the Chairman for the Advisory Board of the University of California, San Diego’s Sulpizio Family Cardiovascular Center and has been the Chairman of the Board of Directors for BIOCOM, a life science industry association in Southern California. He also serves on the Board of Arena Pharmaceuticals. Mr. Woods has a Bachelor’s Degree in Biology and Chemistry and a Master’s Degree in Marketing.